Rahul S. Dalal
Appearances
DateMay 9, 2023BACKGROUND AND AIMS: A treat-to-target (TTT) strategy of striving for symptomatic and endoscopic remission is recommended for the management of inflammatory bowel diseases (IBD). Yet, real-world uptake of TTT strategies has been modest…Presenter
Speakers
- DateMay 18, 2024Background: We compared real-world outcomes of upadacitinib (upa) vs tofacitinib (tofa) for ulcerative colitis (UC) through 52 weeks…
Presenter
Speakers
University of North Carolina School of MedicineBrigham and Women's Hospital - DateMay 18, 2024
Presenters
DateMay 18, 2024Speakers
DateMay 18, 2024MONITORING IBD BY INTESTINAL ULTRASOUND DECREASES TIME TO TREATMENT CHANGE AND TIME TO REMISSION IN COMPARISON TO CONVENTIONAL MANAGEMENT: ANALYSIS OF PATIENTS WITH IBD ON MULTIPLE IBD THERAPIESModerators
Vanderbilt University Medical CenterMayo Foundation for Medical Education and Research
